Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_assertion type Assertion NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_head.
- NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_assertion description "[Recent studies identified an activating mutation in the JAK2 tyrosine kinase (JAK2V617F) in most patients with polycythemia vera and in approximately half of those with essential thrombocythemia and primary myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_provenance.
- NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_assertion evidence source_evidence_literature NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_provenance.
- NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_assertion SIO_000772 17906464 NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_provenance.
- NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_assertion wasDerivedFrom befree-2016 NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_provenance.
- NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_assertion wasGeneratedBy ECO_0000203 NP632601.RAHXY52C9hDmmvD9pWBSBthff-xUPHUn0b2111YHGwlIc130_provenance.